8-K - Aktis Oncology, Inc. - 5.02 / 7.01 / 9.01

Form 8-K - Current report: SEC Accession No. 0001193125-26-158944

Filing Date: 2026-04-16

Accepted: 2026-04-16 16:01:24

Documents: 12

Period of Report: 2026-04-15

Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Aktis Oncology, Inc. (Filer) CIK : 0002035832 (see all company filings) EIN. : 852584233 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-43047 | Film No.: 26867441 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | 8-K | d110479d8k.htm iXBRL | 8-K

2 | EX-99.1 | d110479dex991.htm | EX-99.1

3 | XBRL TAXONOMY EXTENSION SCHEMA | akts-20260415.xsd | EX-101.SCH

4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | akts-20260415_lab.xml | EX-101.LAB